This could suggest that suppression of IKK1/α could possibly halt other pathways due to its wide array of interaction with other proteins, such as IKK2/β, AKT1, MAP4K4, and TRAF2, that are possibly implicated with other cancer pathways. Here, TRAF2 is linked to cancer.